LLY: fourth_quarter 2019 lobbying report

{"url":"https://lda.gov/api/v1/filings/22d73d58-8c23-4678-8440-e0429b76e095/","filing_uuid":"22d73d58-8c23-4678-8440-e0429b76e095","filing_type":"4A","filing_type_display":"4th Quarter - Amendment","filing_year":2019,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.gov/filings/public/filing/22d73d58-8c23-4678-8440-e0429b76e095/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jay Engleson","dt_posted":"2026-07-06T12:12:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9TH STREET STE 650","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":65191,"url":"https://lda.gov/api/v1/registrants/65191/","house_registrant_id":35579,"name":"VENN STRATEGIES","description":"A political and public affairs consulting firm.","address_1":"750 9th St NW, Suite 650","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAY ENGLESON","contact_telephone":"+1 301-509-9933","dt_updated":"2026-08-29T15:03:26.607563-04:00"},"client":{"id":162695,"url":"https://lda.gov/api/v1/clients/162695/","client_id":366,"name":"ELI LILLY AND COMPANY","general_description":"Pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2002-07-23"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25887,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"SILVERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61267,"prefix":null,"prefix_display":null,"first_name":"NATASCHA","nickname":null,"middle_name":null,"last_name":"CUMBERLIDGE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68900,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":"TYLER","last_name":"ROBERTS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64837,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"SPIRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72272,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"TOLLEFSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Tom Reed; Legislative Director, Rep. Randy Hultgren","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}